odiparcil has been researched along with Bleeding in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abboud, MA; Burns-Kurtis, CL; Danoff, TM; Erhardt, JA; Koster, PF; Pillarisetti, K; Toomey, JR; Valocik, RE | 1 |
1 other study(ies) available for odiparcil and Bleeding
Article | Year |
---|---|
A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis.
Topics: Animals; Anticoagulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glycosaminoglycans; Glycosides; Hemorrhage; Heparin Cofactor II; Protamines; Rats; Vena Cava, Inferior; Venous Thrombosis; Warfarin | 2006 |